17-82157948-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001394669.1(CCDC57):c.2041G>A(p.Val681Met) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000289 in 1,552,344 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001394669.1 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC57 | NM_001394669.1 | c.2041G>A | p.Val681Met | missense_variant, splice_region_variant | 14/19 | ENST00000694881.1 | NP_001381598.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC57 | ENST00000694881.1 | c.2041G>A | p.Val681Met | missense_variant, splice_region_variant | 14/19 | NM_001394669.1 | ENSP00000511565 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152158Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000342 AC: 53AN: 154934Hom.: 0 AF XY: 0.000339 AC XY: 28AN XY: 82644
GnomAD4 exome AF: 0.000293 AC: 410AN: 1400066Hom.: 0 Cov.: 34 AF XY: 0.000263 AC XY: 182AN XY: 690826
GnomAD4 genome AF: 0.000256 AC: 39AN: 152278Hom.: 0 Cov.: 33 AF XY: 0.000201 AC XY: 15AN XY: 74468
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 07, 2022 | The c.2041G>A (p.V681M) alteration is located in exon 14 (coding exon 13) of the CCDC57 gene. This alteration results from a G to A substitution at nucleotide position 2041, causing the valine (V) at amino acid position 681 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at